Durvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study
- Resource Type
- Source
- Annals of Oncology. 28:v372
- Subject
0301 basic medicine Oncology medicine.medical_specialty business.industry Phases of clinical research Hematology medicine.disease Head and neck squamous-cell carcinoma 03 medical and health sciences 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine medicine business - Language
- ISSN
- 0923-7534